Three Antidepressants Added To Conditionally Approved List For FAA Medicals

Gemini Sparkle

Key Takeaways:

  • The FAA has conditionally approved three new antidepressants—duloxetine (Cymbalta), venlafaxine (Effexor), and desvenlafaxine (Pristiq)—for pilots.
  • These drugs, which are Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) used for depression and anxiety, require pilots to obtain a special medical issuance.
  • The change became effective on April 24 and was announced via an update to the AME Guide.
See a mistake? Contact us.

The FAA has expanded the list of antidepressants potentially allowed for pilots with three relatively common drugs. Now on the “conditionally approved” list are duloxetine (Cymbalta), venlafaxine (Effexor) and desvenlafaxine (Pristiq). A special issuance is required for active pilots to maintain their medicals. The change took effect April 24 and was covered in an update to the AME Guide.

All three drugs are serotonin and norepinephrine reuptake inhibitors and all are prescribed for depression and anxiety. The work by increasing the activity of serotonin and norepinephrine in the brain.

Russ Niles

Russ Niles is Editor-in-Chief of AVweb. He has been a pilot for 30 years and joined AVweb 22 years ago. He and his wife Marni live in southern British Columbia where they also operate a small winery.
Sign-up for newsletters & special offers!

Get the latest stories & special offers delivered directly to your inbox

SUBSCRIBE